Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Bilsland

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Pharmaceuticals (Basel, Switzerland)|November 10, 2022
Reactivity of Covalent Fragments and Their Role in Fragment Based Drug DiscoveryKirsten McAulay, Alan Bilsland, Marta Bon
Molecular Oncology|June 24, 2022
Fragment-based drug discovery-the importance of high-quality molecule librariesMarta Bon, Alan Bilsland, Justin Bower, et al.
BMC Cancer|January 20, 2005
MDM2 negatively regulates the human telomerase RNA gene promoterJiangqin Zhao, Alan Bilsland, Katrina Jackson, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 4, 2010
Modulation of gene expression using zinc finger-based artificial transcription factorsSabine Stolzenburg, Alan Bilsland, W Nicol Keith, et al.
FEBS Letters|February 15, 2003
Involvement of NF-Y and Sp1 binding sequences in basal transcription of the human telomerase RNA geneJiangqin Zhao, Alan Bilsland, Stacey F Hoare, et al.
Nature Clinical Practice. Oncology|November 3, 2005
Drug insight: Cancer cell immortality-telomerase as a target for novel cancer gene therapiesW Nicol Keith, Alan Bilsland, Maryon Hardie, et al.
Expert Reviews in Molecular Medicine|February 28, 2004
Telomerase-directed molecular therapeuticsW Nicol Keith, Alan Bilsland, T R Jeffry Evans, et al.
Breast Cancer Research : BCR|September 27, 2021
A matrisome RNA signature from early-pregnancy mouse mammary fibroblasts predicts distant metastasis-free breast cancer survival in humansAyman M Ibrahim, Alan Bilsland, Steffen Rickelt, et al.
Journal of Mammary Gland Biology and Neoplasia|July 4, 2023
SFRP1 Expression is Inversely Associated With Metastasis Formation in Canine Mammary TumoursJudith Seitz, Alan Bilsland, Chloé Puget, et al.
Cancer Research|September 17, 2005
Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumorsChristine Dufès, W Nicol Keith, Alan Bilsland, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Pharmaceuticals (Basel, Switzerland)|November 10, 2022
Reactivity of Covalent Fragments and Their Role in Fragment Based Drug DiscoveryKirsten McAulay, Alan Bilsland, Marta Bon
Molecular Oncology|June 24, 2022
Fragment-based drug discovery-the importance of high-quality molecule librariesMarta Bon, Alan Bilsland, Justin Bower, et al.
BMC Cancer|January 20, 2005
MDM2 negatively regulates the human telomerase RNA gene promoterJiangqin Zhao, Alan Bilsland, Katrina Jackson, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 4, 2010
Modulation of gene expression using zinc finger-based artificial transcription factorsSabine Stolzenburg, Alan Bilsland, W Nicol Keith, et al.
FEBS Letters|February 15, 2003
Involvement of NF-Y and Sp1 binding sequences in basal transcription of the human telomerase RNA geneJiangqin Zhao, Alan Bilsland, Stacey F Hoare, et al.
Nature Clinical Practice. Oncology|November 3, 2005
Drug insight: Cancer cell immortality-telomerase as a target for novel cancer gene therapiesW Nicol Keith, Alan Bilsland, Maryon Hardie, et al.
Expert Reviews in Molecular Medicine|February 28, 2004
Telomerase-directed molecular therapeuticsW Nicol Keith, Alan Bilsland, T R Jeffry Evans, et al.
Breast Cancer Research : BCR|September 27, 2021
A matrisome RNA signature from early-pregnancy mouse mammary fibroblasts predicts distant metastasis-free breast cancer survival in humansAyman M Ibrahim, Alan Bilsland, Steffen Rickelt, et al.
Journal of Mammary Gland Biology and Neoplasia|July 4, 2023
SFRP1 Expression is Inversely Associated With Metastasis Formation in Canine Mammary TumoursJudith Seitz, Alan Bilsland, Chloé Puget, et al.
Cancer Research|September 17, 2005
Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumorsChristine Dufès, W Nicol Keith, Alan Bilsland, et al.
Pageof 3